eCommons@AKU
Institute for Human Development

AKU in East Africa

6-2020

Correlates of health-related quality of life among adults receiving
combination antiretroviral therapy in coastal Kenya
Moses K. Nyongesa
Paul Mwangi
Stanley Wanjala
Agnes M. Mutua
Hans M. Koot

See next page for additional authors

Follow this and additional works at: https://ecommons.aku.edu/eastafrica_ihd
Part of the Public Health Commons

Authors
Moses K. Nyongesa, Paul Mwangi, Stanley Wanjala, Agnes M. Mutua, Hans M. Koot, Pim Cuijpers, Charles
R. J. C. Newton, and Amina Abubakar

Nyongesa et al. Health and Quality of Life Outcomes
https://doi.org/10.1186/s12955-020-01421-0

(2020) 18:169

RESEARCH

Open Access

Correlates of health-related quality of life
among adults receiving combination
antiretroviral therapy in coastal Kenya
Moses K. Nyongesa1,2* , Paul Mwangi1, Stanley W. Wanjala3, Agnes M. Mutua1, Hans M. Koot2, Pim Cuijpers2,
Charles R. J. C. Newton1,4,5 and Amina Abubakar1,4,5,6

Abstract
Background: Health-related quality of life (HRQoL) is an important metric of perceived wellbeing in people living
with HIV/AIDS (PLWHA). However, research on HRQoL among PLWHA in sub-Saharan Africa is limited. This study
investigates factors associated with HRQoL among PLWHA in Kilifi, coast of Kenya.
Methods: Between February and April 2018, 450 adults living with HIV and on combined antiretroviral therapy
(cART) between 18 to 60 years were sequentially recruited from an HIV-specialized clinic. The Functional Assessment
of HIV Infection (FAHI) questionnaire, previously adapted for assessing HRQoL in this setting, was slightly modified
and administered to participants alongside other measures of sociodemographic, health and treatment
characteristics in a face-to-face interview.
Results: Linear regression analyses indicated that depressive symptoms, HIV-related stigma, non-disclosure of HIV
status, living alone, clinic inaccessibility, and presence of any current opportunistic infection were significantly
associated with lower HRQoL scores at both the FAHI overall and sub-scale level. Higher physician empathy, male sex,
and higher body mass index were significantly associated with better HRQoL scores at both FAHI overall and sub-scale
level. Age and longer duration on cART were significantly associated with better HRQoL only at the sub-scale level.
Conclusions: Interventions aimed at reducing depressive symptoms and HIV stigma, making HIV-related services more
accessible, addressing opportunistic infections, strengthening social support systems, serostatus disclosure and put in
place caring, respectful, and compassionate model of care are necessary to improve the HRQoL of PLWHA.
Keywords: HIV infections, Adults, Quality of life, Correlates, Psychometrics, Antiretroviral therapy, Kenya

Introduction
As of 2017, 36.9 million people were living with HIV, with
nearly 2 million new HIV infections in the same year [1].
Sub-Saharan Africa (SSA) continues to bear the greatest
HIV-related burden as over half of people living with
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HIV/AIDS (PLWHA) worldwide reside in this region [1].
Nevertheless, strides have been made globally to increase
the availability and accessibility of combined antiretroviral
therapy (cART) for the management of HIV/AIDS even in
low-resource settings of SSA [1]. In Kenya, cART coverage
is reported as 75% among adults [2].
Owing to cART and its adherence, HIV-related morbidity and mortality have declined enormously [3, 4] and life
expectancy of PLWHA has improved [5, 6]. Moreover,
with the advent of cART, HIV – previously considered a
fatal disease – is now managed like any other incurable
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chronic condition [7, 8]. Following the achieved milestones and the evolution of HIV to a chronic and potentially manageable disease, research interest is shifting to
the understanding of the impact of this illness and its
treatment on long-term outcomes such as Health-related
Quality of Life (HRQoL).
HRQoL is multi-dimensional and can be understood as
the patients’ subjective evaluation of themselves based on
perception of the impact of illness and/or its treatment on
their wellbeing [9, 10] in the physical, emotional, social,
cognitive, functional and global domains. It is an important
clinical metric of perceived wellbeing in PLWHA [11].
Evaluating HRQoL of PLWHA in research and clinical
practice may provide important complementary information on patient wellbeing that is not captured by the oftenused biological markers of immune status, namely cluster
of differentiation-4 (CD4) cell count and serum viral load.
These biological markers evaluate HIV progression, but
rarely capture the patient’s experience of treatment benefit
[12]. For PLWHA, attaining longer life expectancy with
antiretroviral treatment is more salient if they can sustain
optimum levels of HRQoL [13].
Several measures are available for assessing HRQoL of
PLWHA. These include HIV-specific instruments such as
the medical outcomes study-HIV [14], the HIV overview of
problems evaluation system [15], the World Health
Organization Quality of Life instrument module for international assessment of HIV/AIDS [16], and the Functional
Assessment of HIV Infection [17]. There is no “gold standard” HRQoL instrument for use with PLWHA per se. The
choice really depends on the purpose of the quality of life
assessment and the most relevant domains of HRQoL that
are specific to research or clinical questions. Noteworthy is
that most of these existing HRQoL measures have been
developed, validated and used in high-resource settings.
However, validation work emerging from low-resource
settings (e.g., Nyongesa et al. [18]), demonstrates that it is
possible to contextually adapt and use these measures.
Various studies, mostly from high-resource settings (see
review by Degroote et al. [8]), but also emerging reports
from SSA [19–22], have investigated factors associated with
HRQoL among PLWHA. From these studies, factors
related to HRQoL in PLWHA can broadly be categorized
as: sociodemographic (such as, age, sex, socioeconomic
status, and family situation; although mixed evidence); clinical and disease-related (such as, viral load, CD4 cell count,
antiretroviral therapy, disclosure, and disease stage and
symptoms); psychological (such as, depressive symptoms,
coping strategy, social support, and HIV-related stigma);
and behavioural (such as, smoking, alcohol and other substance abuse, and cART adherence). Most of these studies
report a negative association between HRQOL and having
depressive symptoms or experiencing HIV-related stigma;
whereas mixed finding is reported for the other variables.

Although HRQoL is an important metric in the course
of HIV disease [11], and should be a primary area of
focus when providing care and support to PLWHA [23];
overall, little research has been conducted to look at
HRQoL and its associated factors among PLWHA in the
SSA context. This study aimed at investigating sociodemographic, clinical and disease-related, psychological, and
behavioural factors as candidate correlates of HRQoL of
adults living with HIV/AIDs from Coastal Kenya who are
under cART management. To our knowledge, the present
study is the first to investigate the HRQoL of PLHIV in the
Coastal region of Kenya using an HIV-specific assessment
measure. In this setting, with a population of 1.4 million
people, the prevalence of adult HIV is estimated at 5% [24].
This study, in addition to emerging reports within SSA
[19–22] adds to the accumulating body of knowledge about
HRQoL of PLWHA living in resource-limited settings.
Studies on correlates of HRQoL are key to informing better
clinical care practices, identifying those in need of extra
support or context-specific priority areas for intervention.
The latter is particularly important in settings where the
disease burden is high, yet resources are limited.
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Methods
Study setting and participants

This work was part of data collected from a larger crosssectional study looking at different outcomes in adults living
with HIV such as mental health, HIV stigma and HRQoL.
The study was conducted at the Centre for Geographic
Medicine Research (CGMR), located in Kilifi County,
Coastal Kenya between 20th February and 15th April 2018.
Participants were patients attending an HIV-specialized
clinic located within the County’s referral hospital. To be included in the larger study, individuals had to be adults, 18 to
60 years old, of confirmed seropositive status, attending the
HIV-specialized clinic for cART management and monitoring and providing consent for participation. Eligible individuals were excluded from the study if they had acute medical
illness or cognitive difficulties at the time of enrolment or
administration of questionnaires. Those who could not
comprehend and/or communicate in Kiswahili (the national
language) which was used during administration of all study
instruments, were excluded from participation. The study
did not include elderly individuals over 60 years living with
HIV because of the increased likelihood of illnesses associated with advancing age, that may have an impact on the
quality of life [25].
Study instruments

For all participants, study instruments were administered
via android tablets by interviewers, in the same order
and under the same administration environment. Administering research assistants received a 4-day training
in research ethics and good interviewing techniques
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(with role plays) and were familiarized with the tabletbased questionnaires.

Higher scores indicate a greater level of perceived HIVrelated stigma. In its original validation, this scale had
acceptable reliability [32].
The Jefferson Scale of Patient’s Perceptions of Physician Empathy (JPPPE) [33] was used to assess patients’
perceptions of their physician’s empathy. The 5 items
are rated on a response set like the HIV stigma scale
above but with an additional option of being “neutral”.
The maximum total score is 25. The higher the score,
the greater the perception of physician empathy. There
is reported evidence in support of the validity and reliability of this scale [34].
Morisky, Green and Levine Medication Adherence
Questionnaire [35]: This 4-item self-report scale was used
to assess adherence to cART using “yes” (1) or “no” (0) response options. Responses of “no” to all the 4 items (total
score of 0) indicates high level of medication taking behaviour. A score of 1 or 2 to all the 4 items indicates medium
adherence whereas a score ≥ 3 is indicative of poor/low
adherence to medication.
Functional assessment of HIV infection (FAHI) questionnaire [17] is an HIV-specific measure that assesses
HRQoL using 5 sub-scales of: Physical wellbeing, Emotional wellbeing, Functional and Global wellbeing, Social
wellbeing and Cognitive functioning. Sub-scales scores
are summed to generate an overall HRQoL score. We
have previously adapted and explored the psychometric
characteristics of a Swahili version of this measure [18].
In this study, the Likert response option was modified
from 3-point to 5-point as a standard format of administering the FAHI regardless of language version as stipulated by the test-developers. Graphical presentation of
response options was used to help participants easily
respond to the 5-point Likert options of “0” (not at all)
through “4” (very much). With this Likert rating, the
possible maximum score after rescaling negative items is
176. Higher scores indicate better HRQoL.

Nyongesa et al. Health and Quality of Life Outcomes

Sociodemographic and asset index forms

These forms were used to collect information on participant’s age, sex, marital status, level of education, employment, and whom they currently lived with. Socioeconomic
status (SES) of study participants was evaluated using an
asset index previously used in this setting [26]. A total
asset score is calculated, higher scores are indicative of
better SES.
Health history and treatment characteristics

A health history form was used to capture information
about patient’s self-reported history of current: smoking,
khat or alcohol use, and presence of any opportunistic
infection or chronic illness (that they were made aware
of by their physician). Also, patients were asked about
disclosure of their HIV status, their satisfaction with
current state of care and perception about clinic accessibility using a “Yes” or “No” response option. In responding to the latter item, participants were asked to
consider the distance between where they currently lived
and the location of the HIV-clinic.
Clinical characteristics

A clinical record form was used to extract information
on cART regimen, viral load (within the last 1 year),
CD4 cell count, HIV clinical stage, dates of HIV diagnosis and cART initiation, most recent weight and height
(for body mass index calculation). All participating
patients gave prior consent for the above information to
be extracted from the clinic’s medical records. We point
out here that there were major missing participant data
on viral load from the database (n = 145) with no followup record of CD4 cell count for all participants.
The 9-item Patient Health Questionnaire (PHQ-9)
[27] was used as a measure of depressive symptoms. It is
rated on a Likert scale of “0” (not at all) to “3” (nearly
every day). Scores of these 9 items are summed to derive
a total score which ranges from 0 to 27. Consistent with
previous studies from SSA [28–30], a cut-off score of
≥10 was used in the present study to define a positive
screen for depressive symptoms. PHQ-9 has previously
been used with PLWHA in Kenya showing acceptable
internal consistency [31].
The 12-item HIV stigma scale [32] was used as a
measure of perceived HIV-related stigma. This scale assesses stigma under four dimensions: i) personalised
stigma; ii) disclosure concerns; iii) negative self-image;
and iv) concerns with public attitudes. Items are rated
on a 4-point Likert scale from “1” (strongly disagree) to
“4” (strongly agree). A total score is derived from summation of item scores and ranges between 12 and 48.

Instrument translation and cross-cultural adaptation

Following World Health Organization’s guidelines
for translation of tools in health research (http://
www.who.int/substance_abuse/research_tools/translation/en/), the English versions of questionnaires not
previously translated and/or adapted into Kiswahili
(HIV-stigma scale, Jefferson’s scale of physician empathy, and the medication adherence questionnaire)
were forward translated by two independent bilingual
translators to Kiswahili. Back translations into English were then undertaken by two other independent
back translators (unaware of the original version). A
group of HIV researchers (natives of Kenya,
knowledgeable about the Kenyan culture, bilingual
and fluent in both English and Kiswahili) and the
translators then held a harmonization meeting to
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review the content, conceptual, semantic and idiomatic
equivalence of the questionnaires [36, 37]. The aim was to
ensure cultural relevance of the questionnaires to the targeted sample. The final versions were obtained following
incorporation of changes resulting from pretesting procedures. The changes were mainly related to administration
procedures as follows:

to be seen by the physician. Those who were able to read
were given the study information sheet (in Kiswahili) to
read on their own. If a consenting patient met inclusion
criteria, administration of study instruments was done
after they were seen by their physician, or as they
awaited to be seen by the physician if the waiting time
was long. Questionnaire administration was conducted
in private rooms within the clinic setting and the entire
interview session lasted between 30 to 45 minutes.

Nyongesa et al. Health and Quality of Life Outcomes

 For the medication adherence scale, it was observed

that some participants were hesitant to talk about
their medication adherence. Since data collection
was conducted within the clinic setting, we presume
they feared the clinic personnel would be informed
of their non-adherence if disclosed. In the final
version of this scale, the following introductory
statement was added re-emphasizing confidentiality
as explained in the consent information sheet: ‘The
following 4 questions will ask about your adherence
to antiretroviral medication. Be assured that the
information you give will be treated with utmost
confidentiality and will be used for this research only.
Your information will not be shared with anyone else
here at the clinic, so feel free to talk’.
 For JPPPE and HIV stigma scale, it was observed
that some participants could not comprehend all the
response options read out to them. In administering
the final versions, all research assistants were
instructed to break down the response options into
simpler options such as ‘do you agree or not agree
(or additionally for JPPPE ‘are neutral’) with this
question’ and depending with a participant’s
response, further probe would follow e.g. ‘do you
strongly agree or simply agree’.

Statistical analyses

Frequencies, percentages, means and standard deviations
were used to describe sample characteristics. In identifying
correlates of HRQoL, prognostic modelling was applied
[40, 41]. Using this approach, all independent variables
which were associated with each of the five sub-scale and
overall scores of the FAHI questionnaire at p < 0.20, in
univariate linear regression analyses, were fitted in a multivariable linear regression model. In the multivariable
model building process, all variables with p > 0.05 were removed (one at a time) in a backward stepwise selection
process. For the final model, the assumptions of leastsquared regression model were checked by visual inspection of: scatter plots and graph matrices (linearity), plots
of residual versus predicted values (homoscedasticity) and
the normal probability plots (normality). Multicollinearity
was checked using variance inflation factor. R (version
3.4.1) statistical software package was used to examine
test-retest reliability and fit indices (for exploring construct validity) of the slightly modified FAHI. All other
analyses were conducted using STATA (version 15.0).

Results
Sample characteristics

Sample size and study power estimation

In the larger cross-sectional study, the sample size of N =
450 was calculated based on prevalence estimate of mental
health outcome [38]. In the present study, this sample size
is > 95% powered (at 5% level of significance) to detect
group differences in overall HRQoL mean scores using
previously reported means and standard deviation across
significant correlates like ethnicity, marital status, employment, CD4 cell count and depressive symptoms, reported
in a past study using the FAHI scale [39].
Study procedures

In the HIV-specialized clinic, usually, health talks (about
half-an hour long) covering topics such as nutrition, adherence or disclosure are presented to all patients before
the start of a day’s clinic services. One of the research
assistants briefly introduced the study at the end of the
daily clinic health talks. Patients who showed interest of
participation were invited for further detailed explanation about the study and for consenting as they awaited

In total, 512 adult patients attending an HIV-specialized
clinic at Kilifi County Hospital for comprehensive care
(including cART management) were approached to participate in this study. Forty-four patients declined to participate. Eighteen patients were excluded because they were
either over 60 years (n = 11), or unable to comprehend and/
or communicate in Kiswahili (n = 7). Consequently, 450
patients, hereafter referred to as study participants, were
consecutively recruited. Table 1 presents the sociodemographic, health, clinical and treatment characteristics of
study participants. The mean age of the study participants
was 42.7 years (SD = 9.7). Most of the participants had
primary level of education (53.1%), were females (79.1%),
unemployed (59.8%), living with family (82.4%), in clinical
stage 1 of HIV (93.7%), and self-reported high adherence to
cART (92.7%).
Participants’ scores on study instruments

Table 2 presents a summary of participants’ scores on the
FAHI, PHQ-9, JPPPE, and HIV-stigma scales disaggregated
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Table 1 Participant characteristics, n = 450
Sociodemographic

Mean/N SD/%

Age – years, mean, SD

42.7

9.7

Sex – Female

356

79.1%

Never married

57

12.7%

Married/cohabiting

196

43.6%

Separated/Divorced/Widowed

197

43.8%

None

123

27.3%

Primary

239

53.1%

Secondary

66

14.7%

Tertiary

22

4.9%

Unemployed/student

269

59.8%

Formally employed

53

11.8%

Self-employed

117

26.0%

Other

11

2.4%

Alone

69

15.3%

Family

371

82.4%

Relative/friend

10

2.2%

1.2

1.4

Currently smoking – Yes, missing = 1

44

9.8%

Current use of khat – Yes

20

4.4%

Marital status

Education

Employment

Currently living with

Asset index score a – mean, SD
Health characteristics

Current alcohol use – Yes, missing = 1

51

11.4%

Any current chronic illness? -Yes

37

8.2%

22.4

4.8

Clinical characteristics
BMI – kg/m2, mean SD, missing = 4
2nd line cART regimen, missing = 4

21

4.7%

Viral load > 1000copies/mL, missing = 145

40

13.1%

Stage 1

417

93.7%

Stage 2

22

4.9%

Stage 3

3

0.7%

WHO clinical stage, missing = 5

Stage 4

3

0.7%

Months since HIV diagnosis – mean, SD

96.8

50.2

Months since cART initiation – mean, SD

81.8

47.1

Treatment characteristics
HIV status disclosure – No

27

6.0%

Any current opportunistic infection? - Yes

83

18.4%

Self-reported cART adherence
High

417

92.7%

Medium/Low

33

7.3%

Clinic accessibility – No, missing = 2

62

13.8%

Satisfaction with current care – No, missing = 1

19

4.2%

Values are n and % unless otherwise stated
SD standard deviation, a - score range = 0 to 7, cART combination
Antiretroviral therapy, BMI body mass index
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by sex. Among all the study participants, the mean overall
FAHI score was 142.98 (SD = 24.56). The median PHQ-9
score was 3 (IQR = 1–7) and using a cut-off score of ≥10,
13.8% (n = 62) of participants had depressive symptoms.
The mean scores on the JPPPE and HIV stigma scale were
22.4 (SD = 3.3) and 28.4 (SD = 7.7), respectively.
Psychometric properties of the study instruments

In the present study, the internal consistency of the PHQ-9
as indicated by Cronbach’s alpha was 0.81 (95% CI: 0.78,
0.84) with a test-retest reliability of 0.78 (95% CI: 0.63,
0.87), based on intra-class correlation coefficient (ICC). The
internal consistency alphas of the JSPPE and the HIV
stigma scale were 0.75 (95% CI: 0.70, 0.81) and 0.81 (95%
CI: 0.78, 0.83), respectively. For the modified FAHI, internal
consistency alpha, test-retest reliability, convergent and
construct validities were all acceptable. Detailed psychometric results of this modified scale are presented as supplementary information. In summary, internal consistency for
the overall FAHI scale was high (Cronbach’s alpha = 0.91;
95% CI: 0.89, 0.92) with sub-scale alphas ranging between
0.57 and 0.88. Test-retest reliability was acceptable for the
overall FAHI scale (ICC = 0.73) and ranged between 0.48
and 0.80 for the sub-scales. Significant correlations were
observed between FAHI scores (sub-scale and overall) with
both PHQ-9 and HIV-stigma scale scores (Supplementary
information, Table 1) suggesting good convergent validity.
Fit indices for investigating construct validity of the FAHI
were all within recommended values (see Supplementary
information, Figure 1).
Correlates of HRQoL among adults receiving cART,
coastal Kenya

Tables 3 and 4 present the results following univariate
and multivariable linear regression analyses. The variable
on viral load was not included in the multivariable regression analysis because many observations had missing
values (n = 145). For all study participants, there were no
any current records of CD4 cell count. Few participants
had some baseline CD4 data (when they were being enrolled to the clinic). Therefore, regression analyses also
missed CD4 cell count information. From the visual inspection of plots, there was evidence to suggest linearity,
homoscedasticity, and normality of generated residuals
in all the final linear regression models. Variance inflation factors did not suggest multicollinearity problems.
In the univariate linear regression analyses, neither
current smoking nor alcohol use was significantly associated with the sub-scale and overall HRQoL scores of the
study participants (at p < 0.05) or even at an a priori set
p < 0.20 for consideration in the multivariable linear
regression analyses.
In the multivariable linear regression analyses, having
depressive symptoms was strongly associated with lower
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Table 2 Participant scores on continuous measures
Measure

Score range

Total sample
N = 450

Male
n = 94

Female
n = 356

Physical wellbeing sub-scale

0–40

30.86 (9.19)

33.78 (8.03)

30.09 (9.33)

Emotional wellbeing sub-scale

0–40

31.98 (8.42)

33.03 (7.39)

31.71 (8.65)

Functional Global wellbeing sub-scale

0–52

44.96 (7.05)

45.89 (5.46)

44.72 (7.04)

Social wellbeing sub-scale

0–32

25.70 (6.25)

27.18 (4.88)

25.31 (6.51)

Cognitive function sub-scale

0–12

9.48 (2.84)

9.87 (2.67)

9.38 (2.88)

Overall scale

0–176

142.98 (24.56)

149.76 (19.75)

141.20 (25.41)

PHQ-9 - median (IQR)

0–27

3 (1–7)

2 (0–6)

3 (1–7)

JPPPE

5–25

22.4 (3.3)

22.3 (3.4)

22.5 (3.3)

12-item HIV-stigma scale

12–48

28.4 (7.7)

26.6 (7.4)

28.9 (7.7)

FAHI scale

All values are means (SD) unless otherwise stated
FAHI functional assessment of HIV infection scale, PHQ-9 9 item patient health questionnaire, IQR inter quartile range, JPPPE Jefferson Scale of Patient’s
Perceptions of Physician Empathy

overall (β = 30.23, 95% CI -35.16, − 25.30; p < 0.01) and
sub-scale HRQoL scores except for the Social wellbeing
domain (Table 4). Similarly, high perceived HIV-stigma
scores were significantly associated with lower overall
(β = − 0.86, 95% CI -1.08, − 0.64; p < 0.01) and sub-scale
HRQoL scores except for the Functional and Global
wellbeing domain (Table 4).
Participants who reported staying alone compared to
those who stayed with family were significantly more
likely to have lower overall (β = − 6.93, 95% CI -11.47, −
2.39; p < 0.01) and sub-scale HRQoL scores except in the
domains of Physical wellbeing and Functional and Global
wellbeing (Table 4). Participants who had not disclosed
their HIV status were significantly more likely to have
lower overall (β = − 15.55, 95% CI -22.50, − 8.60; p < 0.01),
and sub-scale HRQoL scores except in the domains of
Physical wellbeing and Cognitive functioning (Table 4).
Participants who found the HIV-clinic inaccessible relative
to those who found it accessible were significantly more
likely to have lower overall HRQoL scores (β = − 8.23,
95% CI -13.11, − 3.35; p < 0.01), lower quality of life scores
in the Social wellbeing (β = − 1.88, 95% CI -3.39, − 0.38;
p = 0.01), and Cognitive functioning (β = − 0.97, 95% CI
-1.66, − 0.28; p < 0.01) domains, but not for the other subscales (Table 4). Presence of any current opportunistic infection was also significantly associated with lower overall
HRQoL scores (β = − 4.54, 95% CI -8.80, − 0.27; p = 0.04),
and lower quality of life score only in the Emotional wellbeing domain (β = − 2.76, 95% CI -4.27, − 1.24; p < 0.01)
for the studied population.
On the other hand, male sex was significantly associated
with better overall (β = 9.60, 95% CI 5.46, 13.74; p < 0.01)
and sub-scale HRQoL scores except for the Emotional
wellbeing and Cognitive functioning domains (Table 4).
Higher physician empathy was significantly associated
with better overall (β = 1.59, 95% CI 1.09, 2.09; p < 0.01)

and sub-scale HRQoL scores except for the Emotional
wellbeing domain (Table 4). Similarly, a unit increase in
BMI was significantly associated with better overall
HRQoL score (β = 0.66, 95% CI 0.32, 1.01; p < 0.01), better
quality of life score in the Physical wellbeing (β = 0.26,
95% CI 0.11, 0.41; p < 0.01), and Functional and Global
wellbeing (β = 0.23, 95% CI 0.11, 0.35; p < 0.01) but not
Emotional wellbeing, Social wellbeing, and Cognitive functioning domains.
There were no statistically significant association
between any of the proxies for SES (i.e. employment,
education and asset index) and HRQoL (sub-scale or
overall). Similarly, no statistically significant associations
were found between age, duration on cART (in months)
and overall HRQoL. However, significant associations
were found between both age and duration on cART
with Emotional wellbeing domain. As shown in Table 4,
one-year increase in age was significantly associated with
0.08-point higher quality of life scores in Emotional wellbeing. Also, a one-month increase of cART use was
significantly associated with a 0.01-point higher quality
of life scores in the Emotional wellbeing domain.
The final linear regression model consisting of variables on sex, whom the participants currently lived with,
disclosure, clinic accessibility, opportunistic infection,
symptoms of depression, HIV-related stigma, physician
empathy and BMI explained 51.5% of the variance in
overall HRQoL. Variance explained by the final subscale linear regression models are shown in Table 4.

Discussion
In this cross-sectional study, a slightly modified FAHI
scale with acceptable psychometric properties was used
to explore correlates of HRQoL among PLWHA from
the Kenyan coast. Consistent with previous findings
from SSA [19, 22, 26] and elsewhere [8, 11]; this study

Male

−2.66* (− 6.49, 1.17)

−7.00** (− 11.12, − 2.89)

1.42 (− 4.07, 6.92)
− 0.44 (− 2.94, 2.05)

− 0.10 (− 6.04, 5.84)

−3.35** (− 6.05, − 0.66)

Self-employed

Other forms of employment

Unemployed

Yes

Current alcohol use

449

Ref
3.16* (− 0.62, 6.93)

Ref

3.55* (−0.57, 7.67)

1.61 (−1.56, 4.78)

Ref

− 0.48 (− 2.68, 1.73)

Ref

0.46* (− 0.02, 0.94)

− 0.90 (− 2.69, 0.88)

Ref

− 0.04 (− 0.88, 0.80)

0.95 (− 0.90, 2.80)

0.26 (− 0.67, 1.19)

Ref

0.01 (− 1.29, 1.29)

0.49 (− 0.75, 1.74)

0.26 (− 1.12, 1.63)

Ref

0.47 (−2.34, 3.28)

Ref

− 0.23 (− 2.18, 1.73)

Ref

0.55** (0.13, 0.98)

Ref
8.75 (− 2.27, 19.78)

− 0.03 (− 1.31, 1.24)

−2.98 (− 10.65, 4.69)

Ref

1.96** (0.31, 3.62)

− 4.90* (− 11.22, 1.43)

−3.31 (− 18.77, 12.15)

Ref

− 5.16* (− 12.39, 2.08)

7.75 (− 8.20, 23.71)

−1.41 (− 9.38, 6.56)

Ref

− 9.26* (− 20.40, 1.88)

− 3.30** (− 14.02, 7.42)

− 4.06 (− 15.91, 7.79)

Ref

Ref

− 0.27 (− 1.15, 0.61)

Ref

0.07 (− 0.13, 0.26)

−1.66** (− 3.26, − 0.05) − 0.66** (− 1.39, 0.07)

− 1.79 (− 5.71, 2.13)

Ref

0.01 (− 1.83, 1.84)

4.96** (0.91, 9.01)

0.32 (− 1.70, 2.35)

Ref

0.02 (− 2.83, 2.87)

0.65 (− 2.09, 3.39)

− 0.11 (− 3.13, 2.92)

Ref

−9.45** (− 16.63, − 2.27)

−7.79*** (− 12.60, − 2.98)

Ref

8.56*** (3.01, 14.10)

Ref

0.27** (0.03, 0.50)

Overall HRQoL
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No

450

−1.34 (− 4.20, 1.53)

Current khat use

Ref
− 0.67 (−3.30, 1.96)

Ref

0.10 (− 0.47, 0.67)

Yes

449

No

Currently smoking

450 0.79** (0.17, 1.41)

−.191 (− 5.48, 5.10)
−1.99* (− 4.15, 0.18)

−1.22 (−7.02, 4.58)

0.43 (− 1.94, 2.80)

Relative/friend

Alone

Socioeconomic asset index

0.80 (−3.65, 5.24)
−1.02 (− 2.83, 0.80)

Ref

Ref

Ref

−1.33 (− 3.41, 0.75)

0.52 (− 4.07, 5.11)

− 0.04 (− 2.33, 2.26)

Ref

0.38 (− 2.83, 3.59)

1.09 (− 2.00, 4.19)

0.68 (− 2.74, 4.10)

Ref

Family

Currently living with

Ref
− 0.70 (− 3.45, 2.04)

Ref

−1.25 (− 4.22, 1.72)

Formally employed

Employment

450

− 1.36 (− 5.04, 2.33)

−4.17** (−8.13, − 0.21)

Primary

450

− 2.02 (−6.09, 2.06)

−2.88 (− 7.25, 1.50)

Secondary

None

Ref

Ref

450

Tertiary

Education

−2.84** (− 4.91, − 0.77) − 3.06** (− 4.88, −
1.24)

− 3.07** (− 5.54, − 0.61)

0.18 (− 2.53, 2.90)

Never married

− 0.66* (− 1.50, 0.18)

−1.87** (− 3.25, − 0.48) −1.70** (− 2.93, − 0.48) − 0.25 (− 0.81, 0.32)

Ref

Ref

0.49* (− 0.15, 1.14)

−2.32** (− 3.98, − 0.67)

Ref

1.87** (0.46, 3.29)

Ref

Ref

1.17* (− 0.43, 2.78)

Ref

0.01 (−0.02, 0.03)

Cognitive
function domain

−.165* (−3.47, 0.17)

1.33* (−0.59,3.24)

3.69*** (1.62, 5.77)

Ref

0.07** (0.01, 0.13)

Social wellbeing
domain

Separated/divorced/widowed

450

Ref

0.10*** (0.03, 0.17)

Functional Global
wellbeing domain

Married/cohabiting

Marital status

Ref

0.11** (0.03, 0.19)

Emotional wellbeing
domain

Ref

450

Female

Sex

Physical wellbeing
domain

450 −0.03 (− 0.12, 0.06)

N

β-coefficient (95% CI) of HRQoL domains and overall scale as dependent variables

Age

Independent variables

Table 3 Univariate linear regression analysis of correlates of HRQoL among adults receiving cART in Coastal Kenya
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ART adherence

450

Ref
− 4.24** (− 7.93, − 0.55)

Ref

−1.14 (− 5.19, 2.90)

Second line

Ref

Ref

Ref

1.01 (− 2.08, 4.11)

0.98 (− 1.78, 3.73)

Ref

0.01 (− 0.01, 0.01)

−0.01 (− 0.02, 0.01)
Ref

−0.01 (− 0.01, 0.01)

−0.22*** (− 0.29, −
0.15)

− 2.66*** (−4.32, −
1.00)

Ref

−1.23 (− 3.34, 0.87)

Ref

−0.25 (− 1.74, 1.24)

Ref

−0.01 (− 0.02, 0.01)

−0.20*** (− 0.28, −
0.11)

−6.82*** (− 8.61, −
5.03)

Ref

−0.46 (− 2.84, 1.92)

Ref

− 1.37* (− 3.06, 0.31)

Ref

− 4.21** (−7.44, − 0.98) −4.19*** (− 7.05, −
1.33)

Ref

−3.09*** (−4.96, −1.21) − 2.20** (− 3.86, −
0.53)

Ref

−4.06*** (− 6.79, −1.33) −5.04*** (− 7.43, −
2.64)

Ref

− 0.40 (− 2.23, 1.43)

Ref

Social wellbeing
domain

Ref

−18.50*** (− 27.94, − 9.06)

Ref

1.68 (− 5.52, 8.87)

Ref

Overall HRQoL

−37.75*** (− 43.35, −
32.15)

Ref

−5.17 (− 13.45, 3.11)

Ref

−9.20*** (− 15.01, − 3.39)

Ref

−10.97* (− 22.27, 0.32)

Ref

− 0.72 (− 1.97, 0.53)

Ref

−0.01 (− 0.01, 0.01)

−0.01 (− 0.01, 0.01)

−4.11 (− 14.93, 6.71)

Ref

0.02 (− 0.02, 0.07)

− 0.01 (− 0.05, 0.04)

−0.11*** (− 0.14, − 0.07) −1.42*** (− 1.69, − 1.16)

− 3.20*** (− 3.90, −
2.49)

Ref

− 0.26 (− 1.22, 0.70)

Ref

− 0.27 (− 0.95, 0.41)

Ref

− 0.17 (− 1.49, 1.14)

Ref

−1.43*** (− 2.18, − 0.67) −13.15*** (− 19.66, − 6.64)

Ref

−0.36 (− 1.46, 0.75)

Ref

0.05 (− 0.78, 0.88)

Ref

Cognitive
function domain

(2020) 18:169

First line

0.02** (0.01, 0.04)

450 0.01 (−.01, 0.02)

Duration on cART

cART regimen

446

0.01* (− 0.01, 0.03)

450 − 0.01 (− 0.03, 0.01)

Duration since HIV diagnosis

HIV stigma

− 0.54*** (− 0.62, − 0.45)

−12.21*** (− 14.17, −
10.25)

− 12.85*** (− 15.02, −
10.69)

Yes

450 − 0.37*** (− 0.47, − 0.26)

Ref

Ref

No

450

−2.45* (−5.53, 0.66)

Depressive symptom

Ref
−0.77 (− 3.62, 2.06)

Ref

−4.01*** (− 5.99, −2.03)

−3.30*** (−5.47, −1.12)

Yes

450

Ref

Ref

No

Any current chronic illness

Yes

No

450

−0.91 (−4.80, 2.97)

−1.48 (− 5.71, 2.76)

Not satisfied

Any current opportunistic
infection

Ref

Ref

449

Satisfied

Satisfaction with current care

Ref
− 3.05** (− 5.30, − 0.80)

Ref

−3.39** (−5.85, −0.94)

No

448

Yes

Clinic accessible

Ref
−6.44*** (−9.67, −3.21)

Ref

0.54 (− 1.52, 2.61)

−0.11 (− 2.58, 2.36)

1.59 (−1.10, 4.27)

−2.61* (−6.19, 0.97)

Ref

Functional Global
wellbeing domain

Ref

Emotional wellbeing
domain

Ref

Physical wellbeing
domain

β-coefficient (95% CI) of HRQoL domains and overall scale as dependent variables

No

450

N

Yes

Disclosure

Yes

No

Independent variables

Table 3 Univariate linear regression analysis of correlates of HRQoL among adults receiving cART in Coastal Kenya (Continued)
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> 1000 copies

446 0.29*** (0.11, 0.46)

0.20** (0.04, 0.36)

HRQoL health-related quality of life, cART combination antiretroviral therapy, BMI body mass index
*p < 0.20
**p < 0.05
***p < 0.01

BMI

0.31** (0.07, 0.54)

5.41 (− 4.20, 15.03)

2.17 (−8.34, 12.67)

Physician empathy

450 0.37** (0.11, 0.62)

−1.24 (− 4.87, 2.39)
5.08 (− 4.54, 14.70)

−0.83 (−4.80, 3.13)

4.17 (− 6.38, 14.67)

Stage 2

Stage 3

Stage 4

Ref

Ref

Stage 1

WHO staging

Ref
−1.65 (−4.39, 1.09)

Ref

−0.15 (− 3.12, 2.83)

≤1000 copies

445

− 5.02*** (−7.97, − 2.06)

305

−4.92*** (− 8.15, −1.68)

Viral Load

Medium/ Low

Emotional wellbeing
domain
Ref

Physical wellbeing
domain

0.68*** (0.52, 0.84)
0.04 (−0.08, 0.17)

0.23*** (0.10, 0.37)

0.07 (−7.08, 7.22)

4.40 (− 2.74, 11.55)

0.90 (− 1.80, 3.60)

Ref

0.48 (− 1.66, 2.63)

Ref

0.85 (− 1.37, 3.07)

Ref

Social wellbeing
domain

0.73*** (0.54, 0.91)

1.28 (− 6.73, 9.29)

3.61 (− 4.40, 11.62)

−2.37* (− 5.40, 0.65)

Ref

− 2.18* (− 4.57, 0.21)

Ref

−1.66* (− 4.17, 0.84)

Ref

Functional Global
wellbeing domain

β-coefficient (95% CI) of HRQoL domains and overall scale as dependent variables

Ref

N

High

Independent variables

Table 3 Univariate linear regression analysis of correlates of HRQoL among adults receiving cART in Coastal Kenya (Continued)

Ref

Overall HRQoL

Ref

0.04 (−0.02, 0.09)

0.80*** (0.33, 1.27)

2.23*** (1.58, 2.89)

6.79 (− 21.25, 34.84)

− 2.13 (− 5.37, 1.10)
0.15*** (0.07, 0.23)

18.13 (−9.92, 46.17)

− 2.92 (− 13.51, 7.67)

Ref

−4.24 (− 12.29, 3.81)

0.87 (− 2.37, 4.10)

0.62 (− 0.60, 1.84)

Ref

−0.74* (− 1.71, 0.23)

Ref

−1.40*** (− 2.41, −0.40) −12.15*** (− 20.81, − 3.48)

Ref

Cognitive
function domain
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Ref

Ref

−0.22** (− 0.31, − 0.12)

HIV stigma

446

n of the final

R-squared for the final model

45.8%

450

448
23.8%

25.9%

0.60** (0.44, 0.76)

446

0.23** (0.11, 0.35)

0.67** (0.50, 0.85)

−6.22** (−7.89, −4.56)

−2.65** (−3.35, − 1.95)

23.1%

448

0.10** (0.03, 0.17)

−0.07** (− 0.10, − 0.04)

−30.23** (− 35.16, − 25.30)

51.5%

445

0.66** (0.32, 1.01)

1.59** (1.09, 2.09)

−0.86** (− 1.08, − 0.64)

(2020) 18:169

HRQoL health-related quality of life, cART combination antiretroviral therapy, BMI body mass index
*p < 0.05
**p < 0.01

30.9%

0.26** (0.11, 0.41)

BMI

model

0.24* (0.03, 0.46)

Physician empathy

0.01* (0.01, 0.03)

−9.99** (− 11.73, − 8.24)
−0.40** (− 0.48, − 0.32)

−11.09** (−13.25, −8.94)

Yes

Duration on cART

Ref

Ref

No

Ref

−4.54* (−8.80, −0.27)

Depressive symptom

Ref

Ref
−2.76** (−4.27, −1.24)

−8.23** (− 13.11, − 3.35)

Ref

−15.55** (− 22.50, −8.60)

Yes

−0.16** (− 0.22, − 0.09)

−0.97** (− 1.66, − 0.28)

−1.88* (−3.39, −0.38)

Ref

Ref

Ref

−3.96** (− 6.15, − 1.77)

−6.93** (− 11.47, − 2.39)

5.95 (−5.09, 16.99)

Ref

9.60** (5.46, 13.74)

Ref

Overall HRQoL

No

Any current
opportunistic infection

No

Yes

Ref

No

Clinic accessible

Ref
−3.62** (− 6.02, − 1.21)

Ref
−4.36** (−6.88, − 1.83)

Yes

−0.83* (− 1.48, − 0.18)

−1.95** (−3.39, − 0.52)

−2.05* (−3.67, −0.43)

Disclosure

Alone

Ref
−0.18 (− 1.77, 1.41)

Ref
−0.98 (−4.46, 2.50)

2.95 (−1.03, 6.93)

Cognitive function
domain

Ref

2.25** (0.96, 3.53)

Ref

Social wellbeing

Relative/friend

1.67* (0.25, 3.08)

3.24** (1.45, 5.03)

Functional Global
wellbeing domain

Ref

0.08** (0.02, 0.14)

Emotional wellbeing
domain

Ref

Physical wellbeing
domain

β-coefficient (95% CI) of HRQoL domains and full-scale as dependent variables

Family

Currently living with

Male

Female

Sex

Age

Independent variables

Table 4 Multivariable linear regression analysis of correlates of HRQoL among adults receiving cART in Coastal Kenya
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found that presence of depressive symptoms and HIVrelated stigma are associated with lower HRQoL of
PLWHA, both in terms of strength of the association
and the number of associated HRQOL domains (4/5
sub-scales and overall HRQoL). Because causality cannot
be inferred based on the study design, future studies
should explore these consistent findings to help discern
the direction of the observed relationship (e.g., whether
depressive symptoms cause poor HRQoL or vice-versa).
This way, potential interventions, as recommended by
Mekuria et al. [19] can be tested meaningfully.
In this study, there was an association between higher
physician empathy and better HRQoL both overall and
across most sub-scales. Since hardly any study has
looked at physician empathy as a determinant of HRQoL
in the context of HIV/AIDS, it is difficult to compare
our findings. Nonetheless, our finding is comparable to
findings from a recent study looking into the association
between physician empathy and HRQoL in patients with
a chronic condition [42]. There is a need for health care
providers of people living with HIV to practice a
patient-centred care approach. This involves a model of
care that is caring, respectful and compassionate (CRC)
which may contribute to a higher quality of life [43, 44].
The tenets of CRC care model are: i) provision of care
with empathy, ii) effective communication amongst
service providers and between service providers and
patients, iii) respecting a patient’s decision in care, and
iv) personal satisfaction in serving clients as a health
professional.
Following a linear association, higher BMI was strongly
associated with better HRQoL of adults living with HIV/
AIDS from our setting. This finding corroborates findings
from another study conducted in a low-resourced setting
[45], but contrasts results from a study done in highresourced settings [46]. George et al. [46] reported lower
odds of having better quality of life with higher BMI (0.92;
95% CI 0.86, 0.97). We think that on the Kenyan Coast
and other low-resourced settings, where levels of inequality and poverty are high, a higher BMI may just be a proxy
marker for better living situation. For PLWHA who are
required to eat nutritious food regularly (e.g., up to five
servings a day is recommended), higher BMI may be indicative of regular food availability hence better HRQoL. In
an Ethiopian study involving PLWHA, Mekuria et al. [19]
found that sufficient nutritious food was associated with
better HRQoL in most of the domains they assessed. Since
in the West there is hardly food insecurity, the contrasting
finding by George et al. [46] may be because of body size
perception where being overweight or obese is generally
negatively perceived and has been associated with outcomes like depression [47].
In this study, demographic characteristics of sex and
participant current living situation correlated with

HRQoL across 3/5 subscales and overall. Male sex
compared to female was significantly associated with
better Physical wellbeing, Functional and Global wellbeing, Social wellbeing and overall HRQoL. Males having better HRQoL has also been previously reported
elsewhere [8, 48]. Better HRQoL scores among males in
this study could be due to lesser societal demands
hence better social environment compared to females
who in highly patriarchal settings like ours, have additional roles e.g. caregiving and daily house chores yet
must cope with HIV disease and its treatment. Living
alone compared to living with family (immediate or
through marriage) was significantly associated with
lower Emotional wellbeing, Social wellbeing, Cognitive
functioning and overall HRQoL. However, George et al.
[46] comparing quality of life of participants living with
family versus those living alone did not find any significant association. We think that a close family relationship contributes to less emotional problems, more
social contact and better cognitive functioning (all
potentially because of better social support). For instance, living with a stable partner, as family, has been
associated with better mental health aspect of quality of
life [49]. This finding points out the potential significant role of social support in ensuring the wellbeing of
people living with chronic illnesses.
Age as a demographic characteristic was associated with
only Emotional wellbeing, but not any other HRQoL domain in this study. In contrast, younger age has been associated with better HRQoL [19, 50]. A potential explanation
of our finding is that increasing age could facilitate the development of effective coping strategies among the participants which in turn leads to lesser emotional problems
related to living with HIV/AIDS.
Among the treatment characteristics, non-disclosure
and presence of any opportunistic infection were significantly associated with lower HRQoL among study participants. Previous studies have also reported opportunistic
infection [22, 51] as a correlate of HRQoL. In contrast to
our finding, Préau et al. [52] reported that disclosing HIVstatus was associated with poorer physical and mental
health aspects of quality of life. Mainly because of social
support, disclosure of seropositive status could be beneficial for the patient’s mental and physical health [53].
PLWHA should therefore be prepared, encouraged and
supported by service providers to voluntarily disclose their
HIV status to whom they feel comfortable. If a patient is
not willing to disclose, services providers need to respect
this decision, being aware that patients can be confronted
with stigma and discrimination when disclosure is done
involuntarily.
This study found that clinic inaccessibility was associated with lower social wellbeing, cognitive functioning
and overall HRQoL. Hardly any study has explored this
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aspect among PLWHA making it difficult to compare
this finding. A Vietnamese study [54] found a significant
association between access to health care and HRQoL in
univariate but not multivariable analysis. When primary
HIV clinics are far, patients incur extra costs of accessing care such as transportation. Because of poverty,
sometimes they may be forced to borrow from neighbours, friends or other social networks to cater for such
costs. If unable to repay, this may impact on their social
relations and overall functioning as they are concerned
about repayment but also where next to seek help.
A longer duration on cART, another treatment characteristic, was associated with better emotional wellbeing.
Similar findings are reported from a Portuguese study
[55], a study conducted in South India [48] and Nigeria
[56]. In contrast, a study conducted in the central region
of Kenya [57] found longer duration on cART to be
negatively associated with physical health summary but
no significant associations were reported on the mental
health summary. For the observed finding, the authors
put forward an argument that treatment fatigue may
affect adherence with longer duration on cART. In this
study, we argue that continued use of cART gives assurance to the patient of better outcomes e.g. absence (or
fewer) HIV-related symptoms hence lesser emotional
disturbance. This proposition is strengthened by findings
from a qualitative study in Uganda on quality of life
among PLWHA [58]. In this study, one participant
acknowledged the benefits of cART use by saying “they
[cART] have really helped me; I used to be unwell with
fevers, had no appetite and felt tired all the time. I feel
stronger; have no fevers and my skin and body feel and
look better”.

collection and testing) of these biological factors posited
to be correlates of HRQoL [46]. Third and last, our findings may not be generalizable to adults living with HIV/
AIDS in remote areas as study participants were recruited
from an HIV specialized clinic within the Kilifi County
referral hospital which mainly serves the urban and periurban population of Kilifi.

Nyongesa et al. Health and Quality of Life Outcomes

Study strengths and limitations

This study recruited a large number of study participants.
An HIV-specific measure of HRQoL with acceptable
psychometric properties was used. The use of face-to-face
interviews made it possible to assess, among others, the
HRQoL of over a quarter of uneducated participants who
would not have been assessed otherwise. However, the
study is not without limitations which need to be put into
context when interpreting the findings. First, the crosssectional nature of the study design limits any causal inference of the reported study findings. Second, because many
participants had missing information on recent viral load
(n = 145) and none had follow-up data on CD4 counts,
these biomarker data could not be included in regression
analyses. In the presence of an overwhelmingly large number of patients, resource limitations for financing regular
viral load or CD4 tests for monitoring purposes may be a
reason as to why these tests are not done regularly. Future
studies, especially from low-resource settings, should
budget for an objective investigation (i.e. blood sample

Conclusion
HRQoL of PLWHA receiving cART on the Kenyan Coast
is influenced by several factors simultaneously. Depressive
symptoms, HIV-related stigma, non-disclosure of HIV
status, living alone, clinic inaccessibility, and presence of
any current opportunistic infection were correlates of
poor HRQoL. Higher physician empathy, male sex, longer
duration on cART, higher BMI and age were correlates of
better HRQoL.
In improving HRQoL of PLWHA, Mekuria et al. [19]
have previously recommended interventions targeting to
increase nutritional aspects, reduce depressive symptoms
and HIV-related stigma. Additionally, in this context
and similar settings, it is important for programme planners to start thinking about possible ways of making
HIV-related services more accessible and strengthening
the social support structure of PLWHA. For service providers, being empathetic to clients, addressing emerging
opportunistic infections and continually encouraging clients to disclose their HIV-status (at least to trusted few)
may go a long way in enhancing the wellbeing and treatment outcomes of PLWHA.
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